| Stage | LCII | % of rev | HLNE | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $969M | 100.00% | $275M | 100.00% | LCII ×3.52 |
| Gross profit | $301M | 31.09% | $168M | 60.90% | HLNE +29.8pp |
| Operating income | $96M | 9.91% | $126M | 45.93% | HLNE +36.0pp |
| Pre-tax income | $90M | 9.31% | $150M | 54.47% | HLNE +45.2pp |
| Net income | $67M | 6.93% | $125M | 45.36% | HLNE +38.4pp |
| Stage | LCII | HLNE | Gap · A − B |
|---|---|---|---|
| Revenue | $969M100.00% | $275M100.00% | LCII ×3.52 |
| Gross profit | 31.09%$301M | 60.90%$168M | HLNE +29.8pp |
| Operating income | 9.91%$96M | 45.93%$126M | HLNE +36.0pp |
| Pre-tax income | 9.31%$90M | 54.47%$150M | HLNE +45.2pp |
| Net income |
| 6.93%$67M |
| 45.36%$125M |
| HLNE +38.4pp |
No shared counterparties.